Quantum Biopharma Income Statement (2018-2026) | QNTM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Amortization - Intangibles (Quarter)															0.00B	0.00B	0.00B	0.00B		0.00B
Research & Development (Quarter)	0.00B			0.00B				0.00B		0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Share-based Compensation (IS) (Quarter)	0.00B			0.00B				0.00B		0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.01B			0.00B				0.00B	0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Operating Expenses (Quarter)	0.00B			0.00B				0.00B		0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Operating Expenses (Quarter)	0.01B			0.01B				0.01B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Operating Income (Quarter)	-0.01B			0.01B				-0.01B	0.03B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
EBIT (Quarter)	-0.01B			0.01B				-0.01B	0.03B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Non-operating items
Non Operating Investment Income (Quarter)	-0.00B	-0.00B		-0.00B	0.00B	-0.00B		0.00B	-0.00B	0.00B		-0.00B					-0.00B	-0.00B		0.00B
Other Non Operating Income (Quarter)	-0.00B			-0.00B	0.00B	0.00B	-0.00B				0.00B	0.00B		74.00	0.00B	0.00B		0.00B	-0.02B	0.01B
Net income details
EBT (Quarter)	-0.01B			0.01B				-0.01B	0.03B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Profit After Tax (Quarter)	-0.01B	0.01B	-0.06B	0.01B	0.01B	0.01B	-0.05B	-0.01B	0.01B	0.00B	-0.03B	-0.00B	0.00B	0.00B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B
Equity Income (Quarter)																				0.00B
Income from Non-Controlling Interests (Quarter)	-0.01B			0.01B				-0.01B	0.03B	-0.00B	-0.03B	-0.00B	0.00B	-0.00B	-0.01B	0.01B	0.01B	0.00B	-0.00B	-0.01B
Income from Continuing Operations (Quarter)	-0.01B			0.01B				-0.01B	0.03B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Consolidated Net Income (Quarter)	-0.00B			-0.00B				-0.01B	0.03B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Income towards Parent Company (Quarter)	-0.00B			-0.00B				-0.01B	-0.01B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B
Net Income towards Common Stockholders (Quarter)	-0.00B			-0.00B				-0.01B	-0.01B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.01B	-0.00B	-0.01B
Additional items
EPS (Basic) (Quarter)	-0.35	-0.15		0.14	-0.21	-0.19		-0.26	-0.14	-0.03	-0.05	3.43	0.08	4.37	-0.01	-3.53	3.23	-1.25	0.00	3.06
EPS (Weighted Average and Diluted) (Quarter)	0.00			0.00				0.00	-14.08	-0.56		3.43	0.08	4.37		3.53	3.23	1.25	-0.77	3.06
Shares Outstanding (Weighted Average) (Quarter)	0.15B	0.15B	0.00B	0.15B	0.15B	0.15B	0.14B	151.59B	0.00B	0.03B	0.14B	151.62B	41,675.77B	151.70B	0.15B	2,474.97B	159,810.27B	3,801.15B	169,551.04B	4,489.46B
Shares Outstanding (Diluted Average) (Quarter)	35,991.92B	36,296.05B	0.03B	39,998.79B	39,234.86B	38,888.15B		38,962.42B	0.00B	0.00B		610.03B	41,675.77B	917.85B		2,474.97B	3,021.01B	3,801.15B	0.00B	4,489.46B
EBITDA (Quarter)	-0.01B			0.01B				-0.01B	0.03B	-0.00B	-0.01B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B
Interest Expenses (Quarter)	0.00B			0.00B	0.00B	0.00B	-0.00B	667.00		0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B

Research Tools

Developers

Quantum Biopharma Income Statement (2018-2026) | QNTM

Research Tools

Developers

Quantum Biopharma Income Statement (2018-2026) | QNTM

Create an account

Sign In

Reset Password